Compare LPCN & DIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LPCN | DIT |
|---|---|---|
| Founded | 1997 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.8M | 70.9M |
| IPO Year | 2011 | 1996 |
| Metric | LPCN | DIT |
|---|---|---|
| Price | $7.84 | $89.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 98.3K | 974.0 |
| Earning Date | 03-10-2026 | 04-17-2026 |
| Dividend Yield | N/A | ★ 0.74% |
| EPS Growth | ★ 46.18 | N/A |
| EPS | N/A | ★ 1.28 |
| Revenue | $1,976,677.00 | ★ $1,392,388,157.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $74.43 | N/A |
| P/E Ratio | ★ N/A | $70.30 |
| Revenue Growth | N/A | ★ 5.30 |
| 52 Week Low | $2.52 | $80.10 |
| 52 Week High | $12.37 | $126.50 |
| Indicator | LPCN | DIT |
|---|---|---|
| Relative Strength Index (RSI) | 48.94 | 31.52 |
| Support Level | $7.62 | N/A |
| Resistance Level | $8.35 | $119.14 |
| Average True Range (ATR) | 0.62 | 1.79 |
| MACD | 0.04 | -2.85 |
| Stochastic Oscillator | 38.98 | 25.76 |
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.